News: CTE Cryosite says ACCC to review proposed license and sale of certain cord blood and tissue...

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Aug 4 (Reuters) - Cryosite Ltd (CTE) -

    • Australian competition & consumer commission to review proposed license and sale of certain cord blood and tissue assets
    • Cryosite is considering its position in light of notification; proceeding with its plans to seek shareholder approval to proposed transaction
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
70.0¢
Change
0.000(0.00%)
Mkt cap ! $34.16M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 5919 60.5¢
 

Sellers (Offers)

Price($) Vol. No.
75.0¢ 2057 1
View Market Depth
Last trade - 10.00am 08/08/2025 (20 minute delay) ?
CTE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.